Skip to main content
. 2015 Aug 25;27(4):237–245. doi: 10.11919/j.issn.1002-0829.215080

Table 3.

Comparison of mean (sd) outcome measures before and after duloxetine treatment in patients with depression with (n=37) or without (n=40) a history of affective disorders in first-degree relativesa

measure group baseline 2 weeks 4 weeks 6 weeks 8 weeks 12 weeks Ftime (p) Fgroup (p) Ftime*group (p)
HAMD-17 with family history 23.2 (3.7) 14.0 (4.5) 10.1 (3.6) 9.3 (3.4) 8.4 (3.3) 7.8 (3.8) 443.97 (<0.001) 0.01 (0.912) 0.01 (0.938)
without family history 22.8 (3.4) 14.2 (5.0) 10.2 (4.1) 9.4 (3.6) 8.3 (3.5) 7.6 (4.2)
HAMA with family history 20.2 (5.1)a 12.0 (4.1) 9.8 (3.7) 8.0 (3.9) 6.3 (3.0) 5.8 (2.8) 247.04 (<0.001) 0.74 (0.392) 3.01 (0.087)
without family history 17.2 (5.0)a 12.3 (4.4) 9.3 (2.9) 8.3 (2.1) 6.4 (2.5) 5.5 (2.4)
SHAPS with family history 38.9 (4.5)a 31.2 (4.2) 28.5 (3.1) 27.9 (3.1) 27.0 (3.1) 26.3 (3.6) 251.13 (<0.001) 3.95 (0.051) 3.31 (0.073)
without family history 36.2 (5.0)a 29.6 (3.9) 27.5 (3.0) 27.2 (2.8) 26.0 (2.9) 25.7 (3.1)
BDI with family history 16.7 (5.2) 8.5 (3.9) 6.4 (2.3) 6.3 (2.3) 5.7 (2.2) 5.4 (2.6) 260.18 (<0.001) 0.40 (0.530) 0.07 (0.791)
without family history 15.3 (4.4) 8.9 (3.7) 6.6 (2.5) 6.0 (2.3) 5.3 (2.1) 4.9 (2.5)

HAMD-17, 17-item version of the Hamilton Depression rating scale

HAMA, Hamilton Anxiety rating scale

SHAPS, Snaith-Hamilton Pleasure Scale

BDI, Beck Depression Inventory

a except for the baseline scores of HAMA (t=2.59, p=0.012) and SHAPS (t=2.55, p=0.013), there were no statistically significant differences in any of the measures at any of the 6 time periods.